StockData

Addex Therapeutics vs Incannex Healthcare

ADXN and IXHL side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ADXN and IXHL compare

Incannex Healthcare scores higher on the StockData Score (7 against 0 for Addex Therapeutics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricADXNIXHL
Size and price
Market cap–$21.8M
Share price$3.50$1.74
Change, 1 year−58.7%−83.5%
Change, 5 years−97.5%–
Beta (5Y)1.952.40
Employees312
StockData Score
Total score07 (better)
Valuation score01 (better)
Growth score00
Performance score01 (better)
Health score05 (better)
Dividend score00
Valuation
P/B–0.3×
FCF yield–−14.6%
Growth
Revenue growth (TTM)−92.6%–
Revenue growth, 5Y average−61.6%–
EPS growth (TTM)−186%–
Profitability
Operating margin−9391%–
FCF margin−7244%–
Return on equity–−20.7%
Return on invested capital–−1945%
Financial health
Debt / equity–0.00
Interest coverage−181.0×–
Current ratio0.7667.79 (better)
Altman Z-score–−0.22
Piotroski F-score–4
Dividends and buybacks
Buyback yield–−42.2%
Shareholder yield–−42.2%
Ownership
Held by institutions0.00%3.6%
Held by insiders15.5%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.